MergerLinks Header Logo
Cover Image Myrtle Potter
Myrtle PotterSUMITOVANT BIOPHARMA

Myrtle Potter

CEO at SUMITOVANT BIOPHARMA

Manager

Deal Bio

Total Deals3
Valued Deals3
Total Value£1,813M
Avg. Deal Size£604M

Sort

United States
Pharmaceuticals
DomesticPublicAcquisitionMajority
Urovant Sciences

target

Urovant Sciences

Sumitovant Biopharma

bidder

Sumitovant Biopharma

£144m

13 dealmakers

United States
Production Technology Equipment
MinorityPrivate EquityCross BorderVenture CapitalAcquisitionPrivate
Opentrons Labworks

target

Opentrons Labworks

Khosla Ventures

bidder

Khosla Ventures

£146m

7 dealmakers

United Kingdom
Biotechnology
AcquisitionPrivatisationPublicCross BorderMajority
Myovant Sciences

target

Myovant Sciences

Sumitovant Biopharma

bidder

Sumitovant Biopharma

£1,521m

32 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US